These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 1468866)

  • 41. Subacute sclerosing panencephalitis.
    Bellman MH; Dick G
    Postgrad Med J; 1978 Sep; 54(635):587-90. PubMed ID: 724581
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Subacute sclerosing panencephalitis (SSPE) in Poland in 1996-1999. Phase VII of epidemiologic studies].
    Naruszewicz-Lesiuk D; Iwińska-Buksowicz B; Wieczorkiewicz M; Kulczycki J; Gut W
    Neurol Neurochir Pol; 2000; 34(5):877-85. PubMed ID: 11253477
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Subacute sclerosing panencephalitis (SSPE) in Poland 1987-1989. Stage IV of the epidemiological studies].
    Naruszewicz-Lesiuk D; Wieczorkiewicz M; Iwińska B; Kulczycki J; Gut W
    Przegl Epidemiol; 1990; 44(4):265-71. PubMed ID: 2100808
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Changing character of subacute sclerosing panencephalitis in the United States.
    Dyken PR; Cunningham SC; Ward LC
    Pediatr Neurol; 1989; 5(6):339-41. PubMed ID: 2491742
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sero-epidemiology of subacute sclerosing panencephalitis in Delhi.
    Khare S; Kumari S; Sehgal S
    Indian J Med Res; 1990 Mar; 91():94-7. PubMed ID: 2345035
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Subacute sclerosing panencephalitis (SSPE) in Poland in the years 1993-1995. The sixth stage of epidemiological research].
    Naruszewicz-Lesiuk D; Iwińska-Buksowioz B; Wieczorkiewicz M; Kulczycki J; Gut W
    Przegl Epidemiol; 1997; 51(4):371-80. PubMed ID: 9562784
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Subacute sclerosing panencephalitis surveillance study in Istanbul.
    Onal AE; Gurses C; Direskeneli GS; Yilmaz G; Demirbilek V; Yentur SP; Ozel S; Yapici Z; Tumerdem Y; Gökyigit A
    Brain Dev; 2006 Apr; 28(3):183-9. PubMed ID: 16368215
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Subacute sclerosing panencephalitis in Northern Ireland: twenty years' experience.
    Morrow JI; Dowey KE; Swallow MW
    Ulster Med J; 1986 Oct; 55(2):124-30. PubMed ID: 3811010
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Subacute sclerosing panencephalitis: results of the Canadian Paediatric Surveillance Program and review of the literature.
    Campbell C; Levin S; Humphreys P; Walop W; Brannan R
    BMC Pediatr; 2005 Dec; 5():47. PubMed ID: 16356180
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High incidence of subacute sclerosing panencephalitis in south India.
    Saha V; John TJ; Mukundan P; Gnanamuthu C; Prabhakar S; Arjundas G; Sayeed ZA; Kumaresan G; Srinivas K
    Epidemiol Infect; 1990 Feb; 104(1):151-6. PubMed ID: 2307182
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neurological diseases in Karachi, Pakistan--elevated occurrence of subacute sclerosing panencephalitis.
    Kondo K; Takasu T; Ahmed A
    Neuroepidemiology; 1988; 7(2):66-80. PubMed ID: 3374729
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The upsurge of SSPE--a reflection of national measles immunization status in Pakistan.
    Ibrahim SH; Amjad N; Saleem AF; Chand P; Rafique A; Humayun KN
    J Trop Pediatr; 2014 Dec; 60(6):449-53. PubMed ID: 25232151
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Subacute sclerosing panencephalitis in Delhi.
    Khare S; Kumari S; Verghese T
    J Trop Pediatr; 1994 Dec; 40(6):326-8. PubMed ID: 7853435
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adult onset subacute sclerosing panencephalitis: clinical profile of 39 patients from a tertiary care centre.
    Prashanth LK; Taly AB; Ravi V; Sinha S; Arunodaya GR
    J Neurol Neurosurg Psychiatry; 2006 May; 77(5):630-3. PubMed ID: 16464898
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Epidemiologic features of subacute sclerosing panencephalitis from clinical data of patients receiving a public aid for treatment].
    Nakamura Y; Iinuma K; Oka E; Nihei K
    No To Hattatsu; 2003 Jul; 35(4):316-20. PubMed ID: 12875208
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Subacute sclerosing panencephalitis: clinical and demographic characteristics.
    Rafique A; Amjad N; Chand P; Zaidi SS; Rana MS; Ahmed K; Ibrahim S
    J Coll Physicians Surg Pak; 2014 Aug; 24(8):557-60. PubMed ID: 25149833
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Subacute Sclerosing Panencephalitis in Children: The Archetype of Non-Vaccination.
    Papetti L; Amodeo ME; Sabatini L; Baggieri M; Capuano A; Graziola F; Marchi A; Bucci P; D'Ugo E; Kojouri M; Gioacchini S; Marras CE; Nucci CG; Ursitti F; Sforza G; Ferilli MAN; Monte G; Moavero R; Vigevano F; Valeriani M; Magurano F
    Viruses; 2022 Mar; 14(4):. PubMed ID: 35458463
    [TBL] [Abstract][Full Text] [Related]  

  • 58. SSPE: epidemiological and serological features in a series of cases recorded between 1975 and 1984.
    Cernescu C; Cajal N; Popescu-Tismana G
    Virologie; 1985; 36(4):247-54. PubMed ID: 4090270
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Evaluation of changes in the epidemiological situation of SSPE in Poland in the years 1977-1991 (in the course of 15 years after the introduction of mandatory antimeasles vaccination)].
    Naruszewicz-Lesiuk D; Kulczycki J; Iwińska-Buksowicz B; Wieczorkiewicz M; Gut W
    Neurol Neurochir Pol; 1993; 27(3):341-8. PubMed ID: 8232733
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Subacute sclerosing panencephalitis: clinical phenotype, epidemiology, and preventive interventions.
    Mekki M; Eley B; Hardie D; Wilmshurst JM
    Dev Med Child Neurol; 2019 Oct; 61(10):1139-1144. PubMed ID: 30680706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.